First Genetic Trust To Provide Genetic Bank to Pfizer

NEW YORK, Feb. 25 -  First Genetic Trust has signed a deal to provide Pfizer with a genetic bank for pharmacogenomics-based drug discovery, the company said today.

First Genetic Trust, of Chicago, will work with Pfizer to design an informatics-based solution, based on its entrust genetic banking system, that can track and manage access to samples and data in clinical trials that Pfizer is conducting.

The solution will allow users to integrate clinical data, genomic data, and informed consents, in an infrastctucture that complies with FDA regulations on electronic data submission, the company said.